Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
The Secretary of State for Health acting as part of the Crown through the Department of Health and Social Care
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: lynne.nichols@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://cmu.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contract for the supply of live attenuated intranasal influenza vaccine
Reference number: CM/PHV/14/5433
II.1.2) Main CPV code
33651660
II.1.3) Type of contract
Supplies
II.1.4) Short description
Procurement exercise for a contract for the supply of live attenuated intranasal influenza vaccine.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33651600
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Bedford, UK.
II.2.4) Description of the procurement
The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. Deliveries will be required from 1.8.2018 to 31.7.2020 with an option to extend for up to an additional 24 months.
The opportunity was not split into lots as there is only one supplier that holds a marketing authorisation applicable for the UK for this product.
II.2.5) Award criteria
Cost criterion: Price
/ Weighting: N/A
II.2.11) Information about options
Options:
Yes
Description of options:
This contract has the option to be extended for up to an additional 24 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons
Explanation
There is only one manufacturer of this vaccine approved for use in the UK, therefore using the negotiated procedure without prior publication is justified under Regulation 32 (2)(b)(ii) of the Public Contracts Regulations 2015.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2018/S 014-029753
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
09/02/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
AstraZeneca UK Ltd
1 Francis Crick Avenue
Cambridge
CB2 0AA
UK
NUTS: UKH12
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The contract is for the benefit of the Contracting Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non departmental.
Public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s)may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health acting as part of the Crown through the Department of Health and Social Care
Runcorn
UK
VI.5) Date of dispatch of this notice
28/02/2018